Novartis Investigative Site

Lido di Camaiore, LU 55041

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Chronic Heart Failure With Reduced Ejection Fraction, Dyskinesia, Drug-Induced, Heart Failure With Reduced Ejection Fraction, Levodopa, Parkinson Disease, Parkinson's Disease Dementia

Studies at this site

• Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias — Completed
• Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor — Completed
• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD) — Completed